Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 10 » Issue 1

Development of an integral assessment approach of health status in patients with obstructive airway diseases: the CORONA study

Authors van den Akker EF, van ‘t Hul AJ, Chavannes NH, Braunstahl GJ, van Bruggen A, Rutten-van Mölken MP, in ‘t Veen JC

Received 17 June 2015

Accepted for publication 2 October 2015

Published 6 November 2015 Volume 2015:10(1) Pages 2413—2422

DOI https://doi.org/10.2147/COPD.S90680

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Professor Hsiao-Chi Chuang

Peer reviewer comments 3

Editor who approved publication: Dr Richard Russell

Edmée FMM van den Akker,1 Alex J van ‘t Hul,2 Niels H Chavannes,3 Gert-Jan Braunstahl,1 Alie van Bruggen,1 Maureen PMH Rutten-van Mölken,4 Johannes CCM in ‘t Veen1

1Department of Pulmonary Diseases, STZ Center of Excellence for Asthma & COPD, Sint Franciscus Gasthuis, Rotterdam, 2Department of Pulmonary Disease, Radboud University Medical Center, Nijmegen, 3Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, 4Department of Health Care Policy and Management, Institute of Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, the Netherlands

Background: Traditional assessment of patients with obstructive lung diseases (asthma and chronic obstructive pulmonary disease; COPD) relies on physiological tests. The COPD and Asthma Rotterdam Integrated Care Approach (CORONA) study aims to develop a diagnostic pathway with a more comprehensive approach to the assessment of patients with asthma and COPD in secondary care.
Methods: An eight-step method was used to develop and implement the pathway for patients with asthma or COPD referred to an outpatient hospital setting.
Results: The diagnostic pathway consists of an evidence-based set of measurements prioritized by a Delphi procedure. The pathway incorporates three innovative diagnostics: the metronome-paced hyperventilation test to measure dynamic hyperinflation, an activity monitor to objectively evaluate physical activity in daily life, and the Nijmegen Clinical Screening Instrument as a comprehensive assessment tool to acquire detailed insight into symptoms, functional limitations, and quality of life.
Conclusion: An innovative diagnostic pathway was developed and implemented for patients with obstructive lung diseases referred to secondary care. As this pathway aims to provide a comprehensive analysis of health status, it focuses on biomedical aspects and also reviews behavioral aspects that further elucidate the patient’s health status. The added value of the diagnostic pathway needs to be determined from both an organizational perspective and from the individual patient’s viewpoint.

Keywords: diagnostic pathway, integrated care, comprehensive assessment, shared decision-making, health status

Corrigendum for this paper has been published

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author:

Development of an integral assessment approach of health status in patients with obstructive airway diseases: the CORONA study [Corrigendum]

van den Akker EF, van‘t Hul AJ, Chavannes NH, Braunstahl GJ, van Bruggen A, Rutten-van Mölken MP, in ‘t Veen JC

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:191-192

Published Date: 2 February 2016

Readers of this article also read:

The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia

Duman D, Aksoy E, Agca MC, Kocak ND, Ozmen I, Akturk UA, Gungor S, Tepetam FM, Eroglu SA, Oztas S, Karakurt Z

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2469-2478

Published Date: 11 November 2015

COPD: it is time to change!

Tantucci C, Pini L

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2451-2457

Published Date: 11 November 2015

Predicting frequent COPD exacerbations using primary care data

Kerkhof M, Freeman D, Jones R, Chisholm A, Price DB

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2439-2450

Published Date: 9 November 2015

Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients

Wu YQ, Shen YC, Zhang JL, Wan C, Wang T, Xu D, Yang T, Wen FQ

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2405-2412

Published Date: 6 November 2015

Prevalence of chronic obstructive pulmonary disease in asymptomatic smokers

Sansores RH, Velázquez-Uncal M, Pérez-Bautista O, Villalba-Caloca J, Falfán-Valencia R, Ramírez-Venegas A

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2357-2363

Published Date: 2 November 2015

The importance of inhaler devices: the choice of inhaler device may lead to suboptimal adherence in COPD patients

Darbà J, Ramírez G, Sicras A, Francoli P, Torvinen S, Sánchez-de la Rosa R

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2335-2345

Published Date: 29 October 2015

The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units

Sundh J, Johansson G, Larsson K, Lindén A, Löfdahl CG, Sandström T, Janson C

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2327-2334

Published Date: 28 October 2015